Correction
Immunosurveillance and therapy of multiple myeloma are CD226 dependent
Paper Information
Record ID:
13128
Author(s):
Journal:
Publication Date:
April 20, 2015
Retraction Date:
July 01, 2015
(10.4 years years ago)
Subjects:
Institutions:
- Immunology of Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland
- School of Medicine, University of Queensland, Herston, Queensland
- Células Inflamatórias e Neoplásicas group, Universidade Federal do Paraná, Curitiba, Paraná
- Bone Marrow Transplantation, QIMR Berghofer Medical Research Institute, Herston, Queensland
- Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland
- Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri
- Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria
- Comprehensive Cancer Center, Mayo Clinic, Scottsdale, Arizona
- INSERM UMR 1037, Cancer Research Center of Toulouse, Toulouse
Countries:
Article Type:
Publisher:
American Society for Clinical Investigation
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Correction Details
Citations (107)
107
Total Citations100
Post-Retraction(93.5%)
2
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
5
Within 1 year
83
After 2+ years
3531
Days since retraction (latest)
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Mar 2025
3531 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Feb 2025
3516 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Feb 2025
3503 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Jan 2025
3478 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Jan 2025
3472 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Dec 2024
3441 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Sep 2024
3352 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Aug 2024
3348 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Jun 2024
3269 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Apr 2024
3197 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Mar 2024
3178 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Feb 2024
3149 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Jan 2024
3130 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Jan 2024
3127 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Sep 2023
3001 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Jul 2023
2938 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Jul 2023
2922 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Jul 2023
2922 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: May 2023
2866 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Apr 2023
2847 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Jan 2023
2760 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Nov 2022
2693 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Oct 2022
2672 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Aug 2022
2599 days after retraction
CD155 in tumor progression and targeted therapy
Meixiao Zhan, Zhiren Zhang, Xiaoguang Zhao et al. (7 authors)
Cancer Letters
Published: Jul 2022
24 citations
24 citations
2576 days after retraction
Paper citing Stimulation of natural killer cells with a CD137-s...
Unknown Authors
Unknown Journal
Published: Jun 2022
2543 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: May 2022
2503 days after retraction
Paper citing Chimeric Antigen Receptor T Cells for Sustained Re...
Unknown Authors
Unknown Journal
Published: Apr 2022
2494 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Mar 2022
2435 days after retraction
SAR442085, a novel anti-CD38 antibody with enhanced antitumor activity against multiple myeloma
Sahar Kassem, Béré Diallo, Nizar El-Murr et al. (19 authors)
Blood
Open Access
Published: Feb 2022
19 citations
19 citations
2430 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Feb 2022
2407 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Jan 2022
2388 days after retraction
Paper citing Inactivation of PI(3)K p110delta breaks regulatory...
Unknown Authors
Unknown Journal
Published: Oct 2021
2288 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Sep 2021
2281 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Sep 2021
2273 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Sep 2021
2263 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Jul 2021
2192 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Jul 2021
2192 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Jun 2021
2163 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: May 2021
2141 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Mar 2021
2081 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Feb 2021
2067 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Jan 2021
2020 days after retraction
Paper citing Immunosurveillance and therapy of multiple myeloma...
Unknown Authors
Unknown Journal
Published: Dec 2020
1989 days after retraction
Extracellular Vesicles Orchestrate Immune and Tumor Interaction Networks
Kevin Ho Wai Yim, Ala’a Al Hrout, Simone Borgoni et al. (4 authors)
Cancers
Open Access
Published: Dec 2020
28 citations
28 citations
1988 days after retraction
Quick Stats
Total Citations:
107
Years Since Retraction:
10.4 years
Open Access:
Yes
Last Checked:
Never